PPC Stock Analysis: Pilgrims Pride | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 6.574m USD | 12M Return: -28.1% | US72147K1088 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 30.1M
EPS Trend: 25.8%
Qual. Beats: 0
Rev. Trend: 91.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Pilgrims Pride Corporation (NASDAQ: PPC) is a vertically integrated producer and processor of fresh, frozen, and value-added chicken and pork products, serving retail, foodservice, and export markets across the United States, Europe, and Mexico. Its product portfolio spans fresh whole and cut-up chicken, marinated and non-marinated parts, primary pork cuts, fully cooked and ready-to-cook prepared items, as well as growing categories such as plant-based proteins, ready-to-eat meals, multi-protein frozen foods, and desserts. The company markets its products under a wide range of owned and licensed brands, including Pilgrims, Just BARE, Moy Park, Gold Kist, Pierce Chicken, To-Ricos, and Del Dia, among others. Founded in 1946 and headquartered in Greeley, Colorado, Pilgrims Pride operates as a subsidiary of JBS N.V., the global meat and food processing company.
The company operates in the highly consolidated packaged poultry and meats segment of the consumer staples sector, where scale, vertical integration, and supply-chain efficiency are key competitive advantages. Its diversified geographic footprint across North American and European markets helps offset regional demand and commodity cycle volatility, though profitability remains closely tied to feed input costs, labor availability, and processing capacity utilization.
- Chicken breast prices and feed costs drive quarterly margins
- JBS parent company capital allocation influences dividend and buyback policy
- Mexico and Europe prepared foods segment revenue growth offsets US poultry volatility
| Net Income: 320.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -8.12 > 1.0 |
| NWC/Revenue: 8.60% < 20% (prev 7.51%; Δ 1.10% < -1%) |
| CFO/TA 0.09 > 3% & CFO 975.4m > Net Income 320.4m |
| Net Debt (2.98b) to EBITDA (1.13b): 2.63 < 3 |
| Current Ratio: 1.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (239.0m) vs 12m ago 0.21% < -2% |
| Gross Margin: 7.90% > 18% (prev 13.53%; Δ -5.63% > 0.5%) |
| Asset Turnover: 175.5% > 50% (prev 184.4%; Δ -8.90% > 0%) |
| Interest Coverage Ratio: 4.08 > 6 (EBIT TTM 647.1m / Interest Expense TTM 158.5m) |
| A: 0.14 (Total Current Assets 4.47b - Total Current Liabilities 2.89b) / Total Assets 10.9b |
| B: 0.23 (Retained Earnings 2.48b / Total Assets 10.9b) |
| C: 0.06 (EBIT TTM 647.1m / Avg Total Assets 10.4b) |
| D: 0.55 (Book Value of Equity 3.88b / Total Liabilities 7.05b) |
| Altman-Z'' = 2.68 = A |
| DSRI: 0.84 (Receivables 1.01b/1.21b, Revenue 18.3b/18.4b) |
| GMI: 1.71 (GM 13.53% / 7.90%) |
| AQI: 0.92 (AQ_t 0.21 / AQ_t-1 0.23) |
| SGI: 1.00 (Revenue 18.3b / 18.4b) |
| TATA: -0.06 (NI 320.4m - CFO 975.4m) / TA 10.9b) |
| Beneish M = -2.57 (Cap -4..+1) = A |
As of November 04, 2026, the stock is trading at USD 27.28 with a total of 1,474,458 shares traded. Over the past week, the price has changed by +0.70%, over one month by -2.54%, over three months by -2.29% and over the past year by -28.08%.
Current recommended Stop Loss: 25.90 (which is 5.1% or 1.4 ATR below the current price).
Pilgrims Pride has received a consensus analysts rating of 3.38. Therefore, it is recommended to hold PPC.
- StrongBuy: 1
- Buy: 1
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 33 | 21% |
P/E Trailing = 12.0568
P/E Forward = 8.6505
P/S = 0.3566
P/B = 1.6757
P/EG = 0.4882
Revenue TTM = 18.3b USD
EBIT TTM = 647.1m USD
EBITDA TTM = 1.13b USD
Long Term Debt = 3.09b USD (from longTermDebt, last fiscal year)
Short Term Debt = 911k USD (from shortTermDebt, last quarter)
Debt = 3.91b USD (from shortLongTermDebtTotal, last quarter) + Leases 250.7m
Net Debt = 2.98b USD (calculated: Debt 3.91b - CCE 935.8m)
Enterprise Value = 9.55b USD (6.57b + Debt 3.91b - CCE 935.8m)
Interest Coverage Ratio = 4.08 (Ebit TTM 647.1m / Interest Expense TTM 158.5m)
EV/FCF = 408.1x (Enterprise Value 9.55b / FCF TTM 23.4m)
FCF Yield = 0.25% (FCF TTM 23.4m / Enterprise Value 9.55b)
FCF Margin = 0.13% (FCF TTM 23.4m / Revenue TTM 18.3b)
Net Margin = 1.75% (Net Income TTM 320.4m / Revenue TTM 18.3b)
Gross Margin = 7.90% ((Revenue TTM 18.3b - Cost of Revenue TTM 16.9b) / Revenue TTM)
Gross Margin QoQ = 7.17% (prev 7.34%)
Tobins Q-Ratio = 0.87 (Enterprise Value 9.55b / Total Assets 10.9b)
Interest Expense / Debt = 4.05% (Interest Expense 158.5m / Debt 3.91b)
Taxrate = 34.73% (169.7m / 488.6m)
NOPAT = 422.4m (EBIT 647.1m * (1 - 34.73%))
Current Ratio = 1.55 (Total Current Assets 4.47b / Total Current Liabilities 2.89b)
Debt / Equity = 1.01 (Debt 3.91b / totalStockholderEquity, last quarter 3.88b)
Debt / EBITDA = 2.63 (Net Debt 2.98b / EBITDA 1.13b)
Debt / FCF = 127.2 (Net Debt 2.98b / FCF TTM 23.4m)
Total Stockholder Equity = 3.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.07% (Net Income 320.4m / Total Assets 10.9b)
RoE = 8.53% (Net Income TTM 320.4m / Total Stockholder Equity 3.76b)
RoCE = 9.45% (EBIT 647.1m / Capital Employed (Equity 3.76b + L.T.Debt 3.09b))
RoIC = 5.92% (NOPAT 422.4m / Invested Capital 7.13b)
WACC = 3.25% (E(6.57b)/V(10.5b) * Re(3.61%) + D(3.91b)/V(10.5b) * Rd(4.05%) * (1-Tc(0.35)))
Discount Rate = 3.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 97.87 | Cagr: 0.24%
[DCF] Terminal Value 73.10% ; FCFF base≈345.8m ; Y1≈303.3m ; Y5≈245.0m
[DCF] Fair Price = 4.02 (EV 3.93b - Net Debt 2.98b = Equity 956.0m / Shares 238.1m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 25.85 | EPS CAGR: 13.05% | SUE: 0.06 | # QB: 0
Revenue Correlation: 91.84 | Revenue CAGR: 2.18% | SUE: 0.02 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.47 | Chg30d=-3.41% | Revisions=-40% | Analysts=3
EPS current Year (2026-12-31): EPS=1.96 | Chg30d=-18.05% | Revisions=-40% | GrowthEPS=-62.1% | GrowthRev=+0.1%
EPS next Year (2027-12-31): EPS=2.66 | Chg30d=-3.63% | Revisions=-25% | GrowthEPS=+35.9% | GrowthRev=+2.2%
[Analyst] Revisions Ratio: -62% (up=0, down=5)